Archive

Plans to launch the drug in the next couple of months

GRC 27864 is a potent, selective, orally bioavailable inhibitor of mPGES-1

To expand distribution resources in Europe, Americas and Asia

Enhances Actavis' growth platform in Southeast Asia

Actavis and Aurobindo have also entered into a long-term commercial and supply arrangement

The multidisciplinary Oncology Partnership and Education Network (OPEN) aims to improve patient outcomes in oncology, with initial…

{source}<div data-configid="5690019/7312757" style="width: 600px; height: 402px;" class="issuuembed"></div><script…

Data Monitoring Committee (DMC) unanimously recommends early closure

Invites stakeholders for April 1 hearing

Offers customers and employees a standardised knowledge pool for the entire machine portfolio from Bosch Packaging Technology